Cytomegalovirus-associated renal allograft rejection: new challenges for antiviral preventive strategies
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytomegalovirus-associated renal allograft rejection: new challenges for antiviral preventive strategies
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 8, Issue 8, Pages 903-910
Publisher
Informa UK Limited
Online
2010-08-09
DOI
10.1586/eri.10.63
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
- (2010) A. Humar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The 6-Aminoquinolone WC5 Inhibits Human Cytomegalovirus Replication at an Early Stage by Interfering with the Transactivating Activity of Viral Immediate-Early 2 Protein
- (2010) A. Loregian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246
- (2010) P. Lischka et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intragraft cytomegalovirus infection: a randomized trial of valacyclovir prophylaxis versus pre-emptive therapy in renal transplant recipients
- (2010) Tomáš Reischig et al. ANTIVIRAL THERAPY
- International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation
- (2010) Camille N. Kotton et al. TRANSPLANTATION
- Cytomegalovirus in Solid Organ Transplant Recipients
- (2009) A. Humar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The ‘Indirect’ Effects of Cytomegalovirus Infection
- (2009) R. B. Freeman et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients
- (2009) D. Kumar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Effect of Cytomegalovirus Viremia on Subclinical Rejection or Interstitial Fibrosis and Tubular Atrophy in Protocol Biopsy at 3 Months in Renal Allograft Recipients Managed by Preemptive Therapy or Antiviral Prophylaxis
- (2009) Tomáš Reischig et al. TRANSPLANTATION
- Prophylaxis versus Preemptive Protocols for CMV: Do They Impact Graft Survival?
- (2008) G. G. Miller et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The Number of Activating KIR Genes Inversely Correlates with the Rate of CMV Infection/Reactivation in Kidney Transplant Recipients
- (2008) M. Stern et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Improvement in Long-Term Renal Graft Survival due to CMV Prophylaxis with Oral Ganciclovir: Results of a Randomized Clinical Trial
- (2008) V. Kliem et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
- (2008) K. Solez et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation
- (2008) S. K. Arthurs et al. CLINICAL INFECTIOUS DISEASES
- High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function
- (2008) Peter Nickel et al. TRANSPLANT IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started